Cipher Pharmaceuticals Statistics
Total Valuation
TSX:CPH has a market cap or net worth of CAD 414.74 million. The enterprise value is 406.39 million.
| Market Cap | 414.74M |
| Enterprise Value | 406.39M |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:CPH has 25.40 million shares outstanding. The number of shares has increased by 0.84% in one year.
| Current Share Class | 25.40M |
| Shares Outstanding | 25.40M |
| Shares Change (YoY) | +0.84% |
| Shares Change (QoQ) | -1.13% |
| Owned by Insiders (%) | 3.55% |
| Owned by Institutions (%) | 1.49% |
| Float | 14.93M |
Valuation Ratios
The trailing PE ratio is 9.81 and the forward PE ratio is 12.92.
| PE Ratio | 9.81 |
| Forward PE | 12.92 |
| PS Ratio | 5.83 |
| PB Ratio | 2.24 |
| P/TBV Ratio | 6.68 |
| P/FCF Ratio | 9.90 |
| P/OCF Ratio | 9.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.74, with an EV/FCF ratio of 9.70.
| EV / Earnings | 9.43 |
| EV / Sales | 5.72 |
| EV / EBITDA | 10.74 |
| EV / EBIT | 14.57 |
| EV / FCF | 9.70 |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.25 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.01 |
| Interest Coverage | 26.79 |
Financial Efficiency
Return on equity (ROE) is 25.94% and return on invested capital (ROIC) is 15.92%.
| Return on Equity (ROE) | 25.94% |
| Return on Assets (ROA) | 7.90% |
| Return on Invested Capital (ROIC) | 15.92% |
| Return on Capital Employed (ROCE) | 15.04% |
| Weighted Average Cost of Capital (WACC) | 7.10% |
| Revenue Per Employee | 14.22M |
| Profits Per Employee | 8.62M |
| Employee Count | 5 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.36 |
Taxes
| Income Tax | -14.86M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.39% in the last 52 weeks. The beta is 0.48, so TSX:CPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +26.39% |
| 50-Day Moving Average | 17.46 |
| 200-Day Moving Average | 15.78 |
| Relative Strength Index (RSI) | 43.34 |
| Average Volume (20 Days) | 19,337 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:CPH had revenue of CAD 71.10 million and earned 43.09 million in profits. Earnings per share was 1.66.
| Revenue | 71.10M |
| Gross Profit | 58.04M |
| Operating Income | 27.90M |
| Pretax Income | 28.23M |
| Net Income | 43.09M |
| EBITDA | 37.47M |
| EBIT | 27.90M |
| Earnings Per Share (EPS) | 1.66 |
Balance Sheet
The company has 8.95 million in cash and 597,428 in debt, with a net cash position of 8.35 million or 0.33 per share.
| Cash & Cash Equivalents | 8.95M |
| Total Debt | 597,428 |
| Net Cash | 8.35M |
| Net Cash Per Share | 0.33 |
| Equity (Book Value) | 185.29M |
| Book Value Per Share | 7.30 |
| Working Capital | 7.16M |
Cash Flow
In the last 12 months, operating cash flow was 41.91 million and capital expenditures -37,688, giving a free cash flow of 41.88 million.
| Operating Cash Flow | 41.91M |
| Capital Expenditures | -37,688 |
| Depreciation & Amortization | 9.69M |
| Net Borrowing | -57.00M |
| Free Cash Flow | 41.88M |
| FCF Per Share | 1.65 |
Margins
Gross margin is 81.63%, with operating and profit margins of 39.24% and 60.60%.
| Gross Margin | 81.63% |
| Operating Margin | 39.24% |
| Pretax Margin | 39.71% |
| Profit Margin | 60.60% |
| EBITDA Margin | 52.69% |
| EBIT Margin | 39.24% |
| FCF Margin | 58.90% |
Dividends & Yields
TSX:CPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.84% |
| Shareholder Yield | -0.84% |
| Earnings Yield | 10.39% |
| FCF Yield | 10.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for TSX:CPH is 20.64, which is 26.39% higher than the current price. The consensus rating is "Buy".
| Price Target | 20.64 |
| Price Target Difference | 26.39% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 9.13% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSX:CPH has an Altman Z-Score of 9.41 and a Piotroski F-Score of 5.
| Altman Z-Score | 9.41 |
| Piotroski F-Score | 5 |